ACTRN12614000864628尚未招募未知
Prospective Randomized Controlled Trial of Monitored Immunosuppression Dose Reduction for Secondary Prevention of Squamous Cell Carcinoma of the Skin in Kidney Transplant Recipients
Robert Peter Carroll0 个研究点目标入组 98 人开始时间: 2014年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Kidney transplant recipients with a previous squamous cell carcinoma of the skin
- •High levels of Regulatory T cells in peripheral blood
- •Low levels of allo reactive T cells measured by ELISPOT
- •Absence of donor specific allo antibodies
排除标准
- •Presence of a donor specific antibody
- •High levels of allo reactive T cells in peripheral circulation
- •Low levels of Regulatory T cells in blood
研究者
相似试验
招募中
不适用
Prospective Randomized Controlled Trial to evaluate effectiveness of Tranexamic Acid Irrigation on Perioperative Blood Loss During Percutaneous nephrolithotomyBleeding after PCNLBleeding,PCNL,TransamineTCTR20200612002/A84
尚未招募
3 期
Prospective Randomized Controlled Trial to evaluate effectiveness of Virtual Reality to decrease anxiety in officed-based cystoscopy patientsPatient that1.Blindƺ.Cannot tolerated to wear a headset3.Age below 18 yrsVirtual Reality Anxiety CystoscopyTCTR20190914002/A70
招募中
不适用
Prospective Randomized Controlled Trial to evaluate effectiveness of watching movies to decrease anxiety during Extracorporeal Shock Wave Lithotripsyrinary CalculiExtracorporeal Shock Wave LithotripsyTCTR20200316002/A84
尚未招募
3 期
Prospective Randomized Controlled Trial to evaluate effectiveness of adjuvant Silodosin for Improving the Stone-Free Rate after Extracorporeal Shock Wave Lithotripsy in Renal StonesStone free statusTCTR20230502002Rayong Hospital100
招募中
3 期
A Prospective Randomized Controlled Clinical Trial of Prophylactic Cranial Irradiation in Metastatic HER-2 positive Breast Cancer.Metastatic HERDŽ positive breast cancer patientsRisk of brain metastasisHER2 positivePCIMetastatic breast cancerTCTR20170612001Ratchadapiseksompotch research fund235